Drug intelligence / Profile preview

Fresubin

Development stage
Unknown
Lead developer
Fresenius Kabi
Administration
Oral, Enteral
01

Overview

Fresubin is a range of nutritionally complete, high-energy oral nutritional supplements and tube feeds designed for the dietary management of patients with or at risk of disease-related malnutrition. These products are formulated to provide balanced nutrition, including protein (from milk or soya), fats (such as rapeseed oil, sunflower oil, fish oil), carbohydrates (like maltodextrin), fiber (inulin, wheat dextrin, cellulose in some formulations), vitamins, minerals, and trace elements. Some variants are tailored for specific patient needs—for example: - **Fresubin Renal** is adapted for patients with chronic kidney disease or acute kidney injury and features reduced protein and electrolytes[7]. - **Fresubin 1000 Complete** is suitable as a sole source of nutrition and contains 22% energy from protein with added fish oil[4]. - **Fresubin Intensive** provides high protein content for those at risk of malnutrition due to illness[6]. - **Fresubin Jucy Drink** offers a fat-free option suitable for patients with fat malabsorption[8]. All Fresubin products are intended for enteral use only under medical supervision. They are not suitable for infants under three years old or individuals with galactosaemia. The main indications include support during periods of increased nutritional need such as cancer therapy-related diarrhea, perioperative care in gastrointestinal tumors, severe sepsis recovery support, short bowel syndrome management, pre-operative preparation in malnourished patients, dysphagia management after surgery or gastrectomy[5][9][10].

Brand names
Fresubin
Other names
瑞素

Beyond the preview

Go deeper on Fresubin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fresubin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call